Poland· PL-100145066
Budesonide Easyhaler
A budesonide product containing budesonidum, registered in Poland by Orion Corporation. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Budesonide is registered in 15 of 19 countries.
Countries holding a registration under ATC R03BA02 (budesonide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Budesonide · ATC R03BA02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Budesonidum
- Manufacturer
- Orion Corporation
- Country
- Poland (PL)
- ATC code
- R03BA02
- ATC class
- Budesonide
- Defined daily dose
- 0.8 mg, Inhal
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
1 priced- gtin059099903372861 inh.po 100 daw.PLN 64.48
- gtin05909990337293
- gtin05909990337309
- gtin05909991474683
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
686 interactions on record for budesonide.
Graded by severity as the source publishes them — 62 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Budesonide · interactions on record
686 records
- 62 severe
- 260 moderate
- 27 minor
- 337 info
Most severe, free to view
- LonafarnibA16AX20severe
- ConivaptanC03XA02severe
- Bempedoic acidC10AX15severe
- MifepristoneG03XB01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Budesonide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBudesonide 400 CyclocapsTeva UK Ltd
- FinlandBudesonid EasyhalerOrion Corporation
- CzechiaGIONA EASYHALEROrion Corporation, Espoo
- NetherlandsBudesonide 400 Cyclocaps, inhalatiepoeder in harde capsule 400 microgramTeva B.V.
- SpainBUDESONIDA EASYHALER 400 microgramos POLVO PARA INHALACIONOrion Corporation
- ItalyBUDESONIDE VIATRISVIATRIS HEALTHCARE LIMITED
- BelgiumBudesonide Easyhaler 400 µgOrion
- IrelandPulmicort Turbohaler 400 micrograms Inhalation PowderAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Budenofalk, Budo-San
- Belgium · Budenofalk, Budesonid Sandoz
- Bulgaria · Airbudenid, Буденофалк
- Cyprus · Axelovert, Biosonide
- Czechia · Budenofalk, Budenofalk Uno
- Germany · Aquacort, Budapp Nasal
- Denmark · Benarhin, Budenofalk
- Estonia · Budesonid Sandoz, Budesonide
- Spain · Budena, Budesonida
- Finland · Budenofalk, Budesonid Easyhaler Orion
- France · Budésonide Arrow, Budesonide Biogaran
- United Kingdom (Northern Ireland) · Benacort, Benacort Hayfever Relief For Adults
- Greece · Aurid, Axelovert
- Croatia · Budelin Novolizer, Budosan
- Hungary · Budenofalk, Budesonid Easyhaler
- Ireland · Budenofalk, Budesonide Azure
- Iceland · Budesonide Stada, Cortiment
- Italy · Aircort, Bidien
- Liechtenstein · Jorveza, Kinpeygo
- Lithuania · Budenofalk, Budesonide Ferring
- Luxembourg · Budenofalk, Budesonide Eg
- Latvia · Budenofalk, Budesonid Sandoz
- Malta · Budesonida Aldo-Unión, Budesonide Azure
- Netherlands · Budenofalk, Budenofalk Schuim
- Norway · Budenofalk, Budesonid Medical Valley
- Portugal · Aeromax, Budenofalk
- Romania · Budenofalk, Budenofalk Uno
- Sweden · Budaxiro, Budenofalk
- Slovenia · Budenofalk, Budesonid Easyhaler Orion
- Slovakia · Budelin Novolizer, Budenofalk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01ae5c1e-0640-4063-89c2-d451edc0ef6f GET /v1/drugs/01ae5c1e-0640-4063-89c2-d451edc0ef6f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do inhalacji",
"source": "urpl",
"strength": "400 mcg/dawkę",
"packaging": "05909990337286 ¦ Rp ¦ 28699\n1 inhalator 100 dawek, zestaw startowy\n05909990337293 ¦ Rp ¦ 28700\n1 inhalator 100 dawek\n05909990337309 ¦ Rp ¦ 28701\n2 inhalatory 100 dawek\n05909991474683 ¦ Rp ¦ 143526\n3 inhalatory 100 dawek",
"substance": "Budesonidum 400 mcg/dawkę",
"common_name": "Budesonidum",
"pl_product_id": "100145066",
"pozwolenie_nr": "11781",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about budesonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.